Nkarta (NKTX) Operating Leases (2019 - 2026)
Nkarta's (NKTX) quarterly Operating Leases came in at $67.9 million in Q1 2026, down 6.91% year-on-year from $73.0 million in Q1 2025, and down 2.32% quarter-over-quarter from $69.5 million in Q4 2025.
Nkarta (NKTX) Operating Leases (2019 - 2026) Analysis & Trends
Nkarta's Operating Leases history runs 8 years deep, the most recent figure standing at $67.9 million for Q1 2026.
- On a quarterly basis, Operating Leases fell 6.91% year-over-year to $67.9 million in Q1 2026; TTM through Mar 2026 was $67.9 million, a 6.91% decrease from a year earlier, with the FY2025 full-year figure at $69.5 million, down 6.32% from the prior year.
- Operating Leases declined to $67.9 million in Q1 2026 per NKTX's latest filing, from $69.5 million in the prior quarter.
- Across five years, Operating Leases topped out at $85.5 million in Q1 2023 and bottomed at $66.7 million in Q1 2022.
- The 5-year median for Operating Leases is $78.1 million (2022), against an average of $76.2 million.
- Across the five-year window, Operating Leases soared 688.82% in 2022 and fell 10.72% in 2025, its largest moves.
- Year by year, Operating Leases stood at $78.7 million in 2022, then rose by 4.56% to $82.3 million in 2023, then declined by 9.78% to $74.2 million in 2024, then declined by 6.32% to $69.5 million in 2025, then fell by 2.32% to $67.9 million in 2026.
- Per Business Quant, the three latest NKTX Operating Leases figures stand at $67.9 million (Q1 2026), $69.5 million (Q4 2025), and $70.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.92 Mn |
| Dec 31, 2025 | 69.53 Mn |
| Sep 30, 2025 | 70.26 Mn |
| Jun 30, 2025 | 71.63 Mn |
| Mar 31, 2025 | 72.96 Mn |
| Dec 31, 2024 | 74.22 Mn |
| Sep 30, 2024 | 78.69 Mn |
| Jun 30, 2024 | 80.04 Mn |
| Mar 31, 2024 | 81.10 Mn |
| Dec 31, 2023 | 82.27 Mn |
| Sep 30, 2023 | 83.41 Mn |
| Jun 30, 2023 | 84.45 Mn |
| Mar 31, 2023 | 85.54 Mn |
| Dec 31, 2022 | 78.69 Mn |
| Sep 30, 2022 | 78.11 Mn |
| Jun 30, 2022 | 69.41 Mn |
| Mar 31, 2022 | 66.74 Mn |
| Dec 31, 2021 | 9.98 Mn |
| Sep 30, 2021 | 10.35 Mn |
| Jun 30, 2021 | 10.41 Mn |